{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:49:15Z","timestamp":1785840555077,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200228"],"award-info":[{"award-number":["82200228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170200"],"award-info":[{"award-number":["82170200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350101"],"award-info":[{"award-number":["82350101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170201"],"award-info":[{"award-number":["82170201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170190"],"award-info":[{"award-number":["82170190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270216"],"award-info":[{"award-number":["82270216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Enolase 1 (ENO1) is a conserved glycolytic enzyme that regulates glycolysis metabolism. However, its role beyond glycolysis in the pathophysiology of multiple myeloma (MM) remains largely elusive. Herein, this study aimed to elucidate the function of ENO1 in MM, particularly its impact on mitophagy under bortezomib-induced apoptosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The bone marrow of clinical MM patients and healthy normal donors was used to compare the expression level of ENO1. Using online databases, we conducted an analysis to examine the correlation between ENO1 expression and both clinicopathological characteristics and patient outcomes. To investigate the biological functions of ENO1 in MM and the underlying molecular mechanisms involved, we conducted the following experiment: construction of a subcutaneous graft tumor model, co-immunoprecipitation, western blot, quantitative real-time polymerase chain reaction, immunohistochemistry, flow cytometry, and cell functional assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>ENO1 was identified as an unfavorable prognostic factor in MM. ENO1 knockdown suppresses tumorigenicity and causes cell cycle arrest. Inhibition of ENO1-regulated mitophagy sensitizes tumor cells to apoptosis. ENO1 enhanced the stability of the YWHAZ protein by increasing the acetylation of lysine in YWHAZ while antagonizing its ubiquitination, which in turn promoted mitophagy. HDAC6 mediates the deacetylation of YWHAZ by deacetylating the K138 site of YWHAZ. Inhibition of HDAC6 increased YWHAZ acetylation and decreased YWHAZ ubiquitination. Furthermore, combination treatment with bortezomib and pharmaceutical agents targeting ENO1 has synergistic anti-MM effects both in vivo and in vitro.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our data suggest that ENO1 promotes MM tumorigenesis and progression. ENO1 activates mitophagy by promoting the stability of YWHAZ and inhibits apoptosis and thus, leads to the drug resistance. ENO1-dependent mitophagy promotes MM proliferation and suppresses the level of bortezomib-induced apoptosis. Inhibition of ENO1 may represent a potential strategy to reverse the resistance of MM to bortezomib.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12929-024-01101-x","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:02:57Z","timestamp":1737331377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ\/Parkin axis"],"prefix":"10.1186","volume":"32","author":[{"given":"Xuejie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-4559","authenticated-orcid":false,"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"10272","key":"1101_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet (London England). 2021;397(10272):410\u201327.","journal-title":"Lancet (London England)"},{"issue":"1","key":"1101_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-022-01683-w","volume":"22","author":"SR Krishnan","year":"2023","unstructured":"Krishnan SR, Bebawy M. Circulating biosignatures in multiple myeloma and their role in multidrug resistance. Mol Cancer. 2023;22(1):79.","journal-title":"Mol Cancer"},{"issue":"9","key":"1101_CR3","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9(9):e670\u20137.","journal-title":"Lancet Haematol"},{"issue":"2","key":"1101_CR4","first-page":"131","volume":"142","author":"S Bird","year":"2023","unstructured":"Bird S, Pawlyn C. IMiD resistance in multiple myeloma: current understanding of the underpinning biology and clinical impact. Blood. 2023;142(2):131\u201340.","journal-title":"Blood"},{"issue":"2","key":"1101_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.18388\/abp.2005_3466","volume":"52","author":"M Piast","year":"2005","unstructured":"Piast M, et al. Molecular evolution of enolase. Acta Biochim Pol. 2005;52(2):507\u201313.","journal-title":"Acta Biochim Pol"},{"key":"1101_CR6","doi-asserted-by":"publisher","first-page":"614726","DOI":"10.3389\/fgene.2020.614726","volume":"11","author":"FA Almaguel","year":"2020","unstructured":"Almaguel FA, et al. Alpha-enolase: emerging tumor-associated antigen, cancer biomarker, and oncotherapeutic target. Front Genet. 2020;11:614726.","journal-title":"Front Genet"},{"issue":"1","key":"1101_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","volume":"3","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat Cancer. 2022;3(1):75\u201389.","journal-title":"Nat Cancer"},{"issue":"13","key":"1101_CR8","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1038\/s41388-020-1172-0","volume":"39","author":"A Ray","year":"2020","unstructured":"Ray A, et al. Preclinical validation of alpha-enolase (ENO1) as a novel immunometabolic target in multiple myeloma. Oncogene. 2020;39(13):2786\u201396.","journal-title":"Oncogene"},{"issue":"3","key":"1101_CR9","doi-asserted-by":"publisher","first-page":"e104705","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, et al. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021;40(3):e104705.","journal-title":"EMBO J"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","volume":"70","author":"P Robak","year":"2018","unstructured":"Robak P, et al. Drug resistance in multiple myeloma. Cancer Treat Rev. 2018;70:199\u2013208.","journal-title":"Cancer Treat Rev"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"1243997","DOI":"10.3389\/fimmu.2023.1243997","volume":"14","author":"S Forster","year":"2023","unstructured":"Forster S, Radpour R, Ochsenbein AF. Molecular and immunological mechanisms of clonal evolution in multiple myeloma. Front Immunol. 2023;14:1243997.","journal-title":"Front Immunol"},{"issue":"3","key":"1101_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.20492","volume":"113","author":"W Qi","year":"2005","unstructured":"Qi W, et al. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 2005;113(3):359\u201363.","journal-title":"Int J Cancer"},{"issue":"1","key":"1101_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2016.08.014","volume":"348","author":"S Tong","year":"2016","unstructured":"Tong S, et al. 14-3-3\u03b6 promotes lung cancer cell invasion by increasing the snail protein expression through atypical protein kinase C (aPKC)\/NF-\u03baB signaling. Exp Cell Res. 2016;348(1):1\u20139.","journal-title":"Exp Cell Res"},{"issue":"18","key":"1101_CR14","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1002\/pmic.200900126","volume":"9","author":"EJ Davison","year":"2009","unstructured":"Davison EJ, et al. Proteomic analysis of increased parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics. 2009;9(18):4284\u201397.","journal-title":"Proteomics"},{"issue":"16","key":"1101_CR15","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.3390\/ijms21165869","volume":"21","author":"SH Lee","year":"2020","unstructured":"Lee SH, et al. Parkin coordinates platelet stress response in diabetes mellitus: a big role in a small cell. Int J Mol Sci. 2020;21(16):5869.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1101_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.201501002","volume":"210","author":"CL Nezich","year":"2015","unstructured":"Nezich CL, et al. MiT\/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J Cell Biol. 2015;210(3):435\u201350.","journal-title":"J Cell Biol"},{"issue":"5","key":"1101_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1139\/bcb-2014-0065","volume":"92","author":"X Gao","year":"2014","unstructured":"Gao X, et al. Ser9-phosphorylated GSK3\u03b2 induced by 14-3-3\u03b6 actively antagonizes cell apoptosis in a NF-\u03baB dependent manner. Biochem Cell Biol. 2014;92(5):349\u201356.","journal-title":"Biochem Cell Biol"},{"issue":"2","key":"1101_CR18","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1038\/emm.2013.151","volume":"46","author":"YK Lee","year":"2014","unstructured":"Lee YK, et al. Knockdown of 14-3-3\u03b6 enhances radiosensitivity and radio-induced apoptosis in CD133(+) liver cancer stem cells. Exp Mol Med. 2014;46(2):e77.","journal-title":"Exp Mol Med"},{"issue":"6","key":"1101_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.devcel.2009.04.005","volume":"16","author":"LK Nutt","year":"2009","unstructured":"Nutt LK, et al. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Dev Cell. 2009;16(6):856\u201366.","journal-title":"Dev Cell"},{"key":"1101_CR20","first-page":"834","volume-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions, vol. 325. New York: Science; 2009. p. 834\u201340."},{"issue":"1","key":"1101_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13046-020-01597-9","volume":"39","author":"L Hu","year":"2020","unstructured":"Hu L, et al. A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe. J Experimental Clin Cancer Research: CR. 2020;39(1):105.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"1","key":"1101_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12929-022-00813-2","volume":"29","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma. J Biomed Sci. 2022;29(1):32.","journal-title":"J Biomed Sci"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"216118","DOI":"10.1016\/j.canlet.2023.216118","volume":"560","author":"J Ma","year":"2023","unstructured":"Ma J, et al. Enhanced E6AP-mediated ubiquitination of ENO1 via LINC00663 contributes to radiosensitivity of breast cancer by regulating mitochondrial homeostasis. Cancer Lett. 2023;560:216118.","journal-title":"Cancer Lett"},{"issue":"8","key":"1101_CR24","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.xcrm.2021.100370","volume":"2","author":"Y Hamel","year":"2021","unstructured":"Hamel Y, et al. Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis. Cell Rep Med. 2021;2(8):100370.","journal-title":"Cell Rep Med"},{"issue":"5","key":"1101_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.molcel.2011.07.028","volume":"43","author":"JL Andersen","year":"2011","unstructured":"Andersen JL, et al. A biotin switch-based proteomics approach identifies 14-3-3\u03b6 as a target of Sirt1 in the metabolic regulation of caspase-2. Mol Cell. 2011;43(5):834\u201342.","journal-title":"Mol Cell"},{"issue":"27","key":"1101_CR26","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.1021\/bi0346345","volume":"42","author":"PA Sims","year":"2003","unstructured":"Sims PA, et al. Reverse protonation is the key to general acid-base catalysis in enolase. Biochemistry. 2003;42(27):8298\u2013306.","journal-title":"Biochemistry"},{"key":"1101_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.chroma.2014.10.098","volume":"1372C","author":"C Lu","year":"2014","unstructured":"Lu C, et al. Preparation and characterization of vorinostat-coated beads for profiling of novel target proteins. J Chromatogr A. 2014;1372\u00a0C:34\u201341.","journal-title":"J Chromatogr A"},{"key":"1101_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijbiomac.2018.10.034","volume":"121","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Role of RACK1 on cell proliferation, adhesion, and bortezomib-induced apoptosis in multiple myeloma. Int J Biol Macromol. 2019;121:1077\u201385.","journal-title":"Int J Biol Macromol"},{"issue":"19","key":"1101_CR29","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1182\/bloodadvances.2022008241","volume":"7","author":"J Chen","year":"2023","unstructured":"Chen J, et al. TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood Adv. 2023;7(19):5752\u201370.","journal-title":"Blood Adv"},{"issue":"1","key":"1101_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Experimental Clin Cancer Research: CR. 2023;42(1):65.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"8","key":"1101_CR31","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, et al. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 2022;18(8):1879\u201397.","journal-title":"Autophagy"},{"issue":"3","key":"1101_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"X-Q Xie","year":"2023","unstructured":"Xie X-Q, et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33(3):215\u201328.","journal-title":"Cell Res"},{"issue":"5","key":"1101_CR33","doi-asserted-by":"publisher","first-page":"e94304","DOI":"10.1371\/journal.pone.0094304","volume":"9","author":"H Yang","year":"2014","unstructured":"Yang H, et al. Expression of neuron-specific enolase in multiple myeloma and implications for clinical diagnosis and treatment. PLoS ONE. 2014;9(5):e94304.","journal-title":"PLoS ONE"},{"issue":"2","key":"1101_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/auto.7.2.14332","volume":"7","author":"ME Gegg","year":"2011","unstructured":"Gegg ME, Schapira AHV. PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: implications for Parkinson disease pathogenesis. Autophagy. 2011;7(2):243\u20135.","journal-title":"Autophagy"},{"issue":"Pt 6","key":"1101_CR35","first-page":"1488","volume":"125","author":"E Itakura","year":"2012","unstructured":"Itakura E, et al. Structures containing Atg9A and the ULK1 complex independently target depolarized mitochondria at initial stages of parkin-mediated mitophagy. J Cell Sci. 2012;125(Pt 6):1488\u201399.","journal-title":"J Cell Sci"},{"issue":"4","key":"1101_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nsmb.2787","volume":"21","author":"DJ Klionsky","year":"2014","unstructured":"Klionsky DJ, Schulman BA. Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nat Struct Mol Biol. 2014;21(4):336\u201345.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"1101_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40164-022-00321-x","volume":"11","author":"N Zhang","year":"2022","unstructured":"Zhang N, et al. Unraveling the structures, functions and mechanisms of epithelial membrane protein family in human cancers. Experimental Hematol Oncol. 2022;11(1):69.","journal-title":"Experimental Hematol Oncol"},{"issue":"5","key":"1101_CR38","doi-asserted-by":"publisher","first-page":"e0037523","DOI":"10.1128\/jvi.00375-23","volume":"97","author":"Z Li","year":"2023","unstructured":"Li Z, et al. HDAC6 degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to inhibit viral replication. J Virol. 2023;97(5):e0037523.","journal-title":"J Virol"},{"issue":"11","key":"1101_CR39","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1074\/jbc.M110.208884","volume":"286","author":"L Huo","year":"2011","unstructured":"Huo L, et al. Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6. J Biol Chem. 2011;286(11):9280\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"1101_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","volume":"25","author":"BT Scroggins","year":"2007","unstructured":"Scroggins BT, et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell. 2007;25(1):151\u20139.","journal-title":"Mol Cell"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-024-01101-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:03:00Z","timestamp":1737331380000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-024-01101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1186\/s12929-024-01101-x","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Shanghai East Hospital (animal use permission No. TJBB00223101).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}